ערך בספרים למניה: TherapeuticsMD Corp (TXMD)

TherapeuticsMD, Inc. (TXMD) is completing a financial restructuring, focusing on collecting licensing fees to settle its debts. The change in BVPS on the GURU.Markets chart visualizes this process, where the value of 2.35 expresses the metric level. Business resilience is supported by hormone patents and contracts with insurance networks, although geopolitical conflicts and sanctions complicate logistics and the expansion of drugs into foreign markets.

Book value per share determines the intrinsic value of a business by subtracting liabilities from total equity to reveal the investor's actual fundamental cushion. By analyzing the trend of book value per share, one can assess how TherapeuticsMD, Inc. (TXMD) expenditures on environmental plant modernization and waste disposal impact the company's net assets within its sustainable development strategy.